Sabrina Giometto

Department of Clinical and Experimental Medicine, University of Pisa, Italy

Poster(s):

• (B-097) How should we estimate the prevalence of drug use, including polypharmacy?
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (B-068) Impact of andexanet alfa introduction on mortality and thromboembolic events, before and after Tuscan guidelines, in patients treated with rivaroxaban or apixaban with major bleeding
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET